Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Translational Psychiatry|April 21, 2021
Effect of TAAR1/5-HT<sub>1A</sub> agonist SEP-363856 on REM sleep in humansSeth C Hopkins, Nina Dedic, Kenneth S Koblan
Psychiatry Research|May 28, 2013
Catechol-O-methyltransferase genotype as modifier of superior responses to venlafaxine treatment in major depressive disorderSeth C Hopkins, David S Reasner, Kenneth S Koblan
Neurology and Therapy|June 16, 2026
The Economic Impact of Cumulative Metabolic Comorbidity Burden in Schizophrenia: A Claims-Based Analysis of Medical Costs in the United StatesXue Han, Seth C Hopkins, Zhen Zhang, et al.
Schizophrenia Bulletin|October 6, 2017
Transformed PANSS Factors Intended to Reduce Pseudospecificity Among Symptom Domains and Enhance Understanding of Symptom Change in Antipsychotic-Treated Patients With SchizophreniaSeth C Hopkins, Ajay Ogirala, Antony Loebel, et al.
Clinical Drug Investigation|November 9, 2021
Depicting Safety Profile of TAAR1 Agonist Ulotaront Relative to Reactions Anticipated for a Dopamine D2-Based Pharmacological Class in FAERSSeth C Hopkins, Ajay Ogirala, MaryAlice Worden, et al.
Innovations in Clinical Neuroscience|February 8, 2018
Understanding Antipsychotic Drug Treatment Effects: A Novel Method to Reduce Pseudospecificity of the Positive and Negative Syndrome Scale (PANSS) FactorsSeth C Hopkins, Ajay Ogirala, Antony Loebel, et al.
Psychiatry Research|November 23, 2020
Characterization of specific and distinct patient types in clinical trials of acute schizophrenia using an uncorrelated PANSS score matrix transform (UPSM)Seth C Hopkins, Ajay Ogirala, Antony Loebel, et al.
Current Medical Research and Opinion|November 23, 2022
Challenges in the clinical development of non-D2 compounds for schizophreniaSeth C Hopkins, Robert Lew, Courtney Zeni, et al.
Contemporary Clinical Trials|August 4, 2024
A clinical trial inclusion criteria to enrich for patients presenting with canonical symptom structure in bipolar depressionSeth C Hopkins, Sasagu Tomioka, Steven T Szabo, et al.
CNS Spectrums|January 20, 2016
Differences in memory function between 5-HT1A receptor genotypes in patients with major depressive disorderKeith A Wesnes, Seth C Hopkins, Helen J Brooker, et al.
Pageof 6